2026 NPPES data Psychiatry Physician NPI 1578536868 M.D.
Verify on CMS →

RUTH ALLBRITTON, M.D.

Psychiatry Physician in FRIENDSWOOD, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
657
Medicare Part D claims · 48 beneficiaries · Psychiatry Physician avg: 1K
Generic prescribing
95%
generic claims · 5% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$30.03
2 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: RUTH ALLBRITTON, M.D. is a Psychiatry Physician ([object Object]) practicing in FRIENDSWOOD, Texas with a Medicare Part D prescribing footprint of 657 claims across 48 beneficiaries — 5% brand-name prescribing . Industry payments of $30.03 across 2 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: RUTH ALLBRITTON, M.D. filed 657 Medicare Part D claims in 2023 across FRIENDSWOOD, Texas. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board-eligible specialty (heuristic — not verified)

RUTH ALLBRITTON, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

RUTH ALLBRITTON, M.D. at a glance

Quality data not reported

NPI registry status

Active

Issued 02/08/2006

NPI 1578536868

Primary specialty

Psychiatry Physician

High-volume

53,104 US NPIs in this specialty

Medicare Part D claims

657 37% vs specialty avg

2023 prescription claims

Specialty avg: 1,038

Specialty distribution in Texas

How Psychiatry Physician compares to other specialties among Texas providers

Texas providers

Psychiatry Physician share within Texas

1. Psychiatry Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Psychiatry Physician share within Texas

Specialty board-certification context

Estimated specialty board-certified rate — Psychiatry Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Psychiatry Physician ABMS/AOA estimate

Est. board-certified rate (Psychiatry Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Psychiatry Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

RUTH ALLBRITTON, M.D. is a Psychiatry Physician provider practicing in FRIENDSWOOD, Texas, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1578536868. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

RUTH ALLBRITTON, M.D. appears in the CMS NPPES registry as a Psychiatry Physician provider holding M.D. credentials at 1560 W BAY AREA BLVD STE 309, FRIENDSWOOD, TX, 77546, with a listed phone of (832) 726-0720. NPI 1578536868 was issued on 02/08/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ALLBRITTON most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 657 prescription claims written by this provider, covering 48 Medicare beneficiaries and totaling roughly $73K in drug spend, split 5% brand-name and 95% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Psychiatry Physician is a high-volume specialty nationwide, with 53,104 enrolled providers across 56 states and an average of 1,038 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1560 W BAY AREA BLVD STE 309
FRIENDSWOOD, TX 77546

Provider Details

NPI 1578536868
Specialty Psychiatry Physician
Credentials M.D.
Gender Female
NPI Issued 02/08/2006

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for RUTH ALLBRITTON, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$30

Largest payer

Supernus Pharmaceuticals, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to RUTH ALLBRITTON, M.D.. To verify RUTH ALLBRITTON, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

RUTH ALLBRITTON, M.D. — brand share 5.0%
Specialty average (est.)

5% brand-name claims vs 95% generic, on 657 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

657
Total Claims
$73K
Total Drug Cost
48
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
914
Total Day Supply
26,789
Brand vs Generic
5% brand / 95% generic
Brand Drug Cost
$57K
Generic Drug Cost
$16K

Patient Demographics

Average Patient Age
67.2 years
Avg HCC Risk Score
1.33
Gender Split
75% female / 25% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Alprazolam
71
Clonazepam
57
Lamotrigine
46
Dextroamphetamine-Amphetamine
Dextroamphetamine/Amphetamine
34
Gabapentin
34
Bupropion Xl
Bupropion Hcl
32
Escitalopram Oxalate
32
Diazepam
26
Venlafaxine Hcl Er
Venlafaxine Hcl
26
Buspirone Hcl
25

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Psychiatry Physician Overview

How RUTH ALLBRITTON, M.D. fits within the Psychiatry Physician landscape nationally.

53,104
Psychiatry Physician Providers in US
56
States with Psychiatry Physician
1,038
Avg Claims per Provider

RUTH ALLBRITTON, M.D.'s 657 claims are below the specialty average of 1,038.

Nearby Psychiatry Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as ALLBRITTON.

Compare Psychiatry Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is RUTH ALLBRITTON, M.D.'s specialty?
RUTH ALLBRITTON, M.D. specializes in Psychiatry Physician and practices in FRIENDSWOOD, Texas. Credentials: M.D..
How much does RUTH ALLBRITTON, M.D. prescribe under Medicare Part D?
In 2023, RUTH ALLBRITTON, M.D. wrote 657 Medicare Part D claims totaling $73K in drug costs for 48 beneficiaries.
Where is RUTH ALLBRITTON, M.D. located?
RUTH ALLBRITTON, M.D. is located at 1560 W BAY AREA BLVD STE 309, FRIENDSWOOD, TX, 77546. Phone: (832) 726-0720.
What is RUTH ALLBRITTON, M.D.'s NPI number?
RUTH ALLBRITTON, M.D.'s National Provider Identifier (NPI) is 1578536868, issued on 02/08/2006.
Does RUTH ALLBRITTON, M.D. prescribe more brand-name or generic drugs?
RUTH ALLBRITTON, M.D.'s prescribing is 5% brand-name and 95% generic drugs by claim count, with $57K in brand drug costs.
How many Psychiatry Physician providers are there in the US?
There are 53,104 Psychiatry Physician providers across 56 states in the US. The average Psychiatry Physician provider writes 1,038 Medicare Part D claims per year.
What drugs does RUTH ALLBRITTON, M.D. prescribe most often?
Based on 2023 Medicare Part D data, RUTH ALLBRITTON, M.D.'s most frequently prescribed drugs include Alprazolam, Clonazepam, Lamotrigine. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does RUTH ALLBRITTON, M.D. accept Medicare?
RUTH ALLBRITTON, M.D. appears in CMS Medicare data with 657 Part D claims and 48 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify RUTH ALLBRITTON, M.D.'s credentials?
RUTH ALLBRITTON, M.D.'s NPI is 1578536868 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology